Study evaluates the Impact of Trough Level-Based Infliximab Dosing on Clinical and Endoscopic Remissions in Patients with IBD October 13, 2016 (Atlanta and Chicago) - Northwestern University Feinberg School of Medicine and Curant Health have announced a new prospective study entitled, “A Collaborative Study to Evaluate the Efficacy of Prospective Post-Induction Infliximab Dosing Based on […]
Every year, biotech industry leaders throughout the southeastern United States convene at Georgia Bio’s flagship conference. Georgia Bio 2016 was no different as hundreds of professionals representing pharmaceutical manufacturers, patient advocacy groups, innovative growth stage companies, service providers and academic institutions met at the Cobb Galleria Center on September 28th. Gatherings like Georgia Bio provide […]
October 10, 2016 – Atlanta, Georgia – One of the nation’s largest independent 340B specialty pharmacies, Curant Health, announces the expansion of an existing 340B clinic partnership on October 1, 2016: Chattanooga C.A.R.E.S. - Chattanooga, Tennessee Based on its successful personalized medication management programs proven to increase adherence by 69%, reduce hospital readmissions by 86% […]
October 10, 2016 - Curant Health COO, Marc O'Connor, in Specialty Pharmacy Times - Where have we been and where are we now? We have long maintained that medication adherence is the longest lever available to reduce $105 billion to $300 billion in wasted health care spending every year, according to the Institute for Healthcare […]
We are honored to join top healthcare thought leaders, visionaries and industry peers to discuss medical costs and quality of care at this year’s Florida Association of ACOs conference in Orlando, Florida October 13-14. The Florida Association of ACOs (FLAACOs) permits accountable care organizations and healthcare leaders to collaborate on lowering overall medical costs while […]
At Curant Health we are constantly looking at ways to improve medication adherence and improve patient outcomes. One great forum for this kind of activity is events like the 2016 Georgia Bio Summit. We are pleased to announce that we will be attending and presenting at this premiere event on Wednesday, September 28 at the […]
At Curant Health, we owe much of our success effective collaboration with our industry partners including pharmaceutical manufacturers, clinicians, insurers, patients and many incredible 340B and Ryan White entities. In the same spirit of collaboration, we are honored to be part of Health Connect South 2016: Regional Assets, Global Impact. On Wednesday, September 21, Curant […]
September 9, 2016 - Curant Health COO, Marc O'Connor, in Managed Healthcare Executive - Healthcare technology simultaneously grinds away like a rusty squeezebox (i.e., EMRs & interoperability) and advances at breakneck speed in a constant attempt to support the industry sea-change born by the advent of value-based care. Venture capital funding in healthcare information technology […]
Representatives from Curant Health recently celebrated our shared commitment to serving the HIV community with many of our partners attending the National Ryan White Conference on HIV Care and Treatment in Washington, DC. Our reception brought old and new friends together with a focus on Celebrating Our Community. Dr. Jim Raper, Director of the UAB […]
When asked about proportionate stakeholder responsibility – payer, provider, patient, pharmacy - in developing a value-based algorithm in healthcare, is there a singular answer? The short answer, single payer system notwithstanding, is that all stakeholders must share responsibility on cost-versus-cure decision points. A more revealing pair of questions to ask is how long is going […]
